Engineering the perfect (bacterial) cancer therapy

被引:611
作者
Forbes, Neil S. [1 ]
机构
[1] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA
基金
美国国家卫生研究院;
关键词
ATTENUATED SALMONELLA-TYPHIMURIUM; ENTERICA-SEROVAR-TYPHIMURIUM; MURINE TUMOR-MODELS; ENZYME-PRODRUG THERAPY; ESCHERICHIA-COLI NISSLE-1917; POSITRON-EMISSION-TOMOGRAPHY; PROTEIN EXPRESSION THERAPY; GENE-THERAPY; IN-VIVO; TARGETING SALMONELLA;
D O I
10.1038/nrc2934
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
引用
收藏
页码:784 / 793
页数:10
相关论文
共 139 条
  • [1] Attenuated Bacteria as Effectors in Cancer Immunotherapy
    Al-Ramadi, Basel K.
    Fernandez-Cabezudo, Maria J.
    El-Hasasna, Hussain
    Al-Salam, Suhail
    Attoub, Samir
    Xu, Damo
    Chouaib, Salem
    [J]. RECENT ADVANCES IN CLINICAL ONCOLOGY, 2008, 1138 : 351 - 357
  • [2] Potent anti-tumor activity of systemically-administered IL-2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis
    Al-Ramadi, Basel K.
    Fernandez-Cabezudo, Maria J.
    El-Hasasna, Hussain
    Al-Salam, Suhail
    Bashir, Ghada
    Chouaib, Salem
    [J]. CLINICAL IMMUNOLOGY, 2009, 130 (01) : 89 - 97
  • [3] ARAKAWA M, 1968, GANN, V59, P117
  • [4] Salmonella promoters preferentially activated inside tumors
    Arrach, Nabil
    Zhao, Ming
    Porwollik, Steffen
    Hoffman, Robert M.
    McClelland, Michael
    [J]. CANCER RESEARCH, 2008, 68 (12) : 4827 - 4832
  • [5] Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as tool for anti-tumor treatment
    Barbé, S
    Van Mellaert, L
    Theys, J
    Geukens, N
    Lammertyn, E
    Lambin, P
    Anné, J
    [J]. FEMS MICROBIOLOGY LETTERS, 2005, 246 (01) : 67 - 73
  • [6] Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma
    Barnett, SJ
    Soto, LJ
    Sorenson, BS
    Nelson, BW
    Leonard, AS
    Saltzman, DA
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2005, 40 (06) : 993 - 998
  • [7] Visualizing Implanted Tumors in Mice with Magnetic Resonance Imaging Using Magnetotactic Bacteria
    Benoit, Michael R.
    Mayer, Dirk
    Barak, Yoram
    Chen, Ian Y.
    Hu, Wei
    Cheng, Zhen
    Wang, Shan X.
    Spielman, Daniel M.
    Gambhir, Sanjiv S.
    Matin, A.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5170 - 5177
  • [8] Bermudes D, 2000, ADV EXP MED BIOL, V465, P57
  • [9] Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
    Bettegowda, C
    Dang, LH
    Abrams, R
    Huson, DL
    Dillehay, L
    Cheong, I
    Agrawal, N
    Borzillary, S
    McCaffery, JM
    Watson, EL
    Lin, KS
    Bunz, F
    Baidoo, K
    Pomper, MG
    Kinzler, KW
    Vogelstein, B
    Zhou, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) : 15083 - 15088
  • [10] Anti-tumor effects of the bacterium Caulobacter crescentus in murine tumor models
    Bhatnagar, P. K.
    Awasthi, A.
    Nomellini, J. F.
    Smit, J.
    Suresh, M. R.
    [J]. CANCER BIOLOGY & THERAPY, 2006, 5 (05) : 485 - 491